Genentech's Venetoclax Drug For Lymphocytic Leukemia Medicine & Technology Aug 13, 2015 The pharmaceutical company Genentech announced that the Phase II study for Venetoclax has meet its primary endpoint.
Kaymakli Underground City: A Maze of Tunnels Deep Beneath the Earth Where Ancient Turkish Lived for Centuries
SPACE Alien Approaches US Military Convoy To Ask for Spare Part and Refuses To Seek Help at Area 51, UFO Whistleblower Claims
SPACE Boeing’s Starliner Crewed Mission Delayed Again Due to Helium Leak, Now Targeting May 25 Launch
SPACE NASA Releases High-Definition Photos of Jupiter’s Moon Europa With Complex Surface Features Called ‘The Platypus’